Netherlands Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Netherlands Pharmaceuticals and Healthcare Report Q4 2013 Aug 7th 2013, 00:00, by rnrmahesh BMI View: We maintain our subdued outlook on the Dutch pharmaceutical and healthcare sector for the remainder of 2013 and looking forward into 2014. With further essential structural reform to the public sector on the horizon, leading to excessive budget deficits, we see economic recovery being put on hold. We therefore do not expect the pharmaceutical industry to return to positive growth until 2016 at the earliest. The Dutch on average spend 14% less on medicines than the rest of Western Europe, and uptake of generic medicines, encouraged by patent expiries and insurers’ preference policies, will result in continuing negative … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110353. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/netherlands-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions